BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Hand holding gear, dollar sign

Sientra reports record quarter as COVID-19 affects guidance

March 12, 2020
By Liz Hollis
Sientra Inc., of Santa Barbara, Calif., reported gains in both its breast products and Miradry segments during its fourth-quarter earnings call after the close of the market March 11. For his part, CEO Jeff Nugent noted that the company had experienced record total net sales in the fourth quarter of $23.2 million, representing growth of 22% year-on-year. However, the company provided full-year 2020 guidance for 12% to 17% growth, which William Blair’s Margaret Kaczor said was below her organization’s 22% estimate, “though the shortfall is largely a result of negative impacts from COVID-19.”
Read More
Coronavirus and DNA

Inovio snags $5M Gates Foundation grant for COVID-19 vaccine delivery device

March 12, 2020
By Meg Bryant
As the COVID-19 strain of coronavirus continues to spread around the globe, companies are scrambling to develop effective diagnostics and vaccines to contain the outbreak and reduce future threats. Among those is Inovio Pharmaceuticals Inc., of Plymouth Meeting, Pa., which has been awarded a $5 million grant from the Bill & Melinda Gates Foundation to speed testing and scale of smart delivery device for its COVID-19 vaccine candidate.
Read More

Other news to note for March 12, 2020

March 12, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aeterna Zentaris, Aldeyra, Arctic Vision, Biogen, Chembio, Clearside, Context, Dendreon, Denovo, Edesa, Emergent, Evofem, Flagship, Hepion, Immunoprecise, Innovation, Inventabiotech, Karolinska, Lumiradx, Mallinckrodt, Medicago, Merck, Novocure, Olix, PDL, Pluristem, Predictive, Rubius, Sareum, Soluble, Sutro, TTF, Tyligand, Vir, Zelluna .
Read More

Financings for March 12, 2020

March 12, 2020
Biopharmas raising money in public or private financings, including: Aytu, Compugen, Exuma, Harbour, Imara, Kymera, Lattice, Nurix, Protalix, Seelos, Tiziana.
Read More
Earth infected with pandemic

Officially a pandemic, but COVID-19 fight far from over, says WHO director general

March 11, 2020
By Nuala Moran
LONDON – The World Health Organization (WHO) has officially declared COVID-19 a pandemic, but is pushing back strongly against countries giving up on stringent control measures.
Read More

Other news to note for March 11, 2020

March 11, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biobeat, Brii Biosciences, Dante Labs, Datawalk, Deephealth, Doctorlink, Ebsco, Fluidigm, Genmark Diagnostics, Hawkeye Systems, IBM Watson, Intabio, Kaiser Permanente, Ntd Eurofins, Parallax, Protein Metrics, Radnet, Tomi Environmental Solutions, Viracor Eurofins.
Read More

Regulatory front for March 11, 2020

March 11, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Heartware, Medtronic.
Read More
U.S. Capitol building

Bills to ensure safety, supply of drugs and devices take first step toward passage

March 11, 2020
By Mari Serebrov
Taking a breather from the political rhetoric that’s permeated the U.S response to COVID-19 and pushed legislation aimed at lowering drug prices to the back burner, a House subcommittee Wednesday advanced several bipartisan bills intended to improve the safety and ensure the supply of drugs and medical devices.
Read More
Stephen Hahn, FDA commissioner

FDA’s Hahn says need to deploy test for SARS-CoV-2 across platforms delayed development

March 11, 2020
By Mark McCarty
U.S. FDA commissioner Stephen Hahn appeared before a congressional panel to discuss the administration’s budget proposal for the agency, but the outbreak of COVID-19 predictably dominated the proceedings.
Read More
3-11-CHF-Aquadex.png

CHF Solutions looks to bring its tech to help COVID-19 patients

March 11, 2020
By Liz Hollis
As the COVID-19 outbreak continues to dominate the news, an increasing number of companies have come forward to help. For its part, CHF Solutions Inc., of Eden Prairie, Minn., is looking to bring its device-based intervention for fluid management to the fight.
Read More
Previous 1 2 … 517 518 519 520 521 522 523 524 525 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Chengdu Mfs Pharma synthesizes new compounds for pain

    BioWorld Science
    Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing